Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Rapid corneal adrenochrome deposition from topical ibopamine in the setting of infectious keratitis.

Bhosai SJ, Lin CC, Greene J, Bloomer MM, Jeng BH.

Eye (Lond). 2013 Jan;27(1):105-6. doi: 10.1038/eye.2012.217. Epub 2012 Oct 19. No abstract available.

2.

Pigmented deposits on a Boston keratoprosthesis from topical ibopamine.

Kanoff JM, Colby K.

Cornea. 2010 Sep;29(9):1069-71. doi: 10.1097/ICO.0b013e3181d07567.

PMID:
20567201
3.

Corneal ciprofloxacin precipitation during bacterial keratitis.

Wilhelmus KR, Abshire RL.

Am J Ophthalmol. 2003 Dec;136(6):1032-7.

PMID:
14644213
4.
5.

[Ibopamine: the message, the messenger and the need of pharmacoepidemiological research].

Stricker BH, Feenstra J, Ottervanger JP.

Ned Tijdschr Geneeskd. 1996 Apr 13;140(15):848-50. Dutch. No abstract available.

PMID:
8668281
6.

Deposits of topical norfloxacin in the treatment of bacterial keratitis.

Castillo A, Benitez del Castillo JM, Toledano N, Diaz-Valle D, Sayagues O, Garcia-Sanchez J.

Cornea. 1997 Jul;16(4):420-3.

PMID:
9220239
7.

Treatment of mild heart failure: the place of diuretics and ibopamine.

Van Veldhuisen DJ.

Eur Heart J. 1997 May;18(5):712-4. No abstract available.

8.

The effects of ibopamine on glomerular filtration rate and plasma norepinephrine remain preserved during prolonged treatment in patients with congestive heart failure.

Lieverse AG, Girbes AR, Van Veldhuisen DJ, Smit AJ, Zijlstra JG, Meijer S, Lie KI, Reitsma WD.

Eur Heart J. 1995 Jul;16(7):937-42.

PMID:
7498209
9.

Effect of topical antioxidant therapy on experimental infectious keratitis.

AliĆ³ JL, Artola A, Serra A, Ayala MJ, Mulet ME.

Cornea. 1995 Mar;14(2):175-9.

PMID:
7743801
10.

The effect of topical ceftazidime on pseudomonas keratitis in rabbits.

Kremer I, Robinson A, Braffman M, Drucker M, Goldenfeld M, Samra Z, Myszne-Daye N, Gaton D, Savir H.

Cornea. 1994 Jul;13(4):360-3.

PMID:
7924338
11.

Flavobacterium meningosepticum keratitis successfully treated with topical trimethoprim-sulfamethoxazole.

Bucci FA Jr, Holland EJ.

Am J Ophthalmol. 1991 Jan 15;111(1):116-8. No abstract available.

PMID:
1985480
12.

Risk factors for mortality in users of ibopamine.

Feenstra J, in't Veld BA, van der Linden PD, Grobbee DE, Stricker BH.

Br J Clin Pharmacol. 1998 Jul;46(1):71-7.

13.

Treatment of Mycobacterium chelonae keratitis with amikacin, doxycycline and topical ciprofloxacin.

Probst LE, Brewer LV, Hussain Z, Tokarewicz AC.

Can J Ophthalmol. 1994 Apr;29(2):81-4. No abstract available.

PMID:
8069760
14.

Increased incidence of corneal perforation after topical fluoroquinolone treatment for microbial keratitis.

Mallari PL, McCarty DJ, Daniell M, Taylor H.

Am J Ophthalmol. 2001 Jan;131(1):131-3.

PMID:
11162991
15.

Dopamine agonists in heart failure: an untimely death.

Smit AJ, Girbes AR.

Neth J Med. 1997 Nov;51(5):151-3. No abstract available.

PMID:
9455093
16.

Topical ciprofloxacin for treating nontuberculous mycobacterial keratitis.

Hu FR, Luh KT.

Ophthalmology. 1998 Feb;105(2):269-72.

PMID:
9479286
17.

A nested case-control study on mortality in users of ibopamine.

Stricker BH, Feenstra J, Ottervanger JP, Porsius AJ, Grobbee DE.

Neth J Med. 1997 Nov;51(5):163-8.

PMID:
9455095
18.

The comparison of topical ibopamine 2% with tonography to identify the outflow resistance in eyes with ocular hypertension.

Hepsen IF, Yilmaz H, Keskin UC.

Ophthalmic Res. 2005 Jan-Feb;37(1):17-22. Epub 2004 Dec 20.

PMID:
15627837
19.

Effects of adrenergics, adrenolytics, cholinergics and carbonic anhydrase inhibitors on ibopamine-induced ocular hypertension in POAG.

Virno M, De Gregorio F, D'Ubaldo E, Sallucci S, De Stefano C, Sedran L.

Acta Ophthalmol Scand Suppl. 1997;(224):25-6. No abstract available.

PMID:
9589717
Items per page

Supplemental Content

Write to the Help Desk